References
- Cayen M. N., Ferdinandi E. S., Greselin E., Dvornik D. The metabolic disposition of etodolac in rats, dogs, and man. Drug Metabolism Reviews 1981; 12: 339–362
- Duggan D. E., Hooke K. F., Noll R. M., Hucker H. B., Van Arman C. J. Comparative disposition of sulindac and metabolites in five species. Biochemical Pharmacology 1978; 27: 2311–2320
- Hicks D. R., Hangeland J. J., Mobilio D., DeLange B. Synthesis of ‘14C’-labelled A7–30,068. Journal of Labelled Compounds and Radiopharmaceuticals 1988; 25: 89–95
- Hucker H. B., Kwan K. C., Duggan D. E. Pharmacokinetics and metabolism of nonsteroidal anti-inflammatory drugs. Progress in Drug Metabolism 1980; 5: 165–253
- Illing H. P. A., Fromson J. M. Species differences in the disposition and metabolism of 6,11-dihydro-11-oxodibenz‘be’oxepin-2-acetic acid (isoxepac) in rat, rabbit, dog, rhesus monkey, and man. Drug Metabolism and Disposition 1978; 6: 510–517
- Morrison B. J., Franklin R. A. A rapid, hygienic method for the preparation of fecal samples for liquid scintillation counting. Analytical Biochemistry 1978; 85: 79–85
- Ray J. E., Wade D. N. The pharmacokinetics and metabolism of ‘14C’carprofen in man. Biopharmaceutics and Drug Disposition 1982; 3: 29–38
- Rubio F., Seawall S., Pocelinko R., DeBarbieri B., Benz W., Berger L., Morgan L., Pao J., Williams T. H., Koechlin B. Metabolism of carprofen, a nonsteroidal antiinflammatory agent, in rats, dogs, and humans. Journal of Pharmaceutical Sciences 1980; 11: 1245–1523